Ownership history in NATIXIS · 6 quarters on record
This page tracks every 13F SEC filing in which NATIXIS reported a position in IOVANCE BIOTHERAPEUTICS INC (IOVA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 20,479 | -23,801 | -53.8% | 0.00% | $44K | $2.17 |
| 2025 Q2 | ADDED | 44,280 | +28,291 | +176.9% | 0.00% | $76K | $1.72 |
| 2023 Q2 | ADDED | 15,989 | +14,949 | +1437.4% | 0.00% | $113K | $7.04 |
| 2023 Q1 | REDUCED | 1,040 | -142,000 | -99.3% | 0.00% | $6K | $6.11 |
| 2022 Q1 | ADDED | 143,040 | +131,909 | +1185.1% | 0.01% | $2.4M | $16.65 |
| 2021 Q2 | INITIATED | 11,131 | — | — | 0.00% | $290K | $26.02 |
As of 2025 Q4 — sorted by position size